vs
FS Bancorp, Inc.（FSBW）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是FS Bancorp, Inc.的1.9倍（$75.5M vs $40.0M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 12.0%），FS Bancorp, Inc.自由现金流更多（$51.9M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.2%）
FS Bancorp, Inc.是总部位于美国的银行控股公司，为华盛顿第一安全银行的母公司，主要面向美国太平洋西北地区客户提供各类个人及商业银行服务，包括存款产品、住房贷款、小微企业融资、建筑贷款等，核心业务涵盖零售银行、商业银行及住房信贷三大板块。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FSBW vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$40.0M
营收增速更快
PBYI
高出15.7%
12.0%
自由现金流更多
FSBW
多$37.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.0M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 25.8% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 12.0% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $1.11 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBWPBYI
| Q4 25 | $40.0M | $75.5M | ||
| Q3 25 | $39.3M | $54.5M | ||
| Q2 25 | $37.3M | $52.4M | ||
| Q1 25 | $36.1M | $46.0M | ||
| Q4 24 | $35.7M | $59.1M | ||
| Q3 24 | $37.2M | $80.5M | ||
| Q2 24 | $36.3M | $47.1M | ||
| Q1 24 | $35.5M | $43.8M |
净利润FSBWPBYI
| Q4 25 | — | — | ||
| Q3 25 | $9.2M | $8.8M | ||
| Q2 25 | $7.7M | $5.9M | ||
| Q1 25 | $8.0M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $10.3M | $20.3M | ||
| Q2 24 | $9.0M | $-4.5M | ||
| Q1 24 | $8.4M | $-4.8M |
毛利率FSBWPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率FSBWPBYI
| Q4 25 | 25.8% | 22.7% | ||
| Q3 25 | 29.5% | 17.6% | ||
| Q2 25 | 26.2% | 12.7% | ||
| Q1 25 | 26.2% | 8.7% | ||
| Q4 24 | 27.6% | 22.6% | ||
| Q3 24 | 26.5% | 27.4% | ||
| Q2 24 | 31.3% | -4.6% | ||
| Q1 24 | 29.7% | -5.3% |
净利率FSBWPBYI
| Q4 25 | — | — | ||
| Q3 25 | 23.4% | 16.2% | ||
| Q2 25 | 20.7% | 11.2% | ||
| Q1 25 | 22.2% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 27.6% | 25.2% | ||
| Q2 24 | 24.7% | -9.6% | ||
| Q1 24 | 23.7% | -11.0% |
每股收益（稀释后）FSBWPBYI
| Q4 25 | $1.11 | $0.26 | ||
| Q3 25 | $1.18 | $0.17 | ||
| Q2 25 | $0.99 | $0.12 | ||
| Q1 25 | $1.01 | $0.06 | ||
| Q4 24 | $0.88 | $0.40 | ||
| Q3 24 | $1.29 | $0.41 | ||
| Q2 24 | $1.13 | $-0.09 | ||
| Q1 24 | $1.06 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $307.7M | $130.3M |
| 总资产 | $3.2B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FSBWPBYI
| Q4 25 | $28.2M | $97.5M | ||
| Q3 25 | $61.3M | $94.4M | ||
| Q2 25 | $33.2M | $96.0M | ||
| Q1 25 | $62.7M | $93.2M | ||
| Q4 24 | $31.6M | $101.0M | ||
| Q3 24 | $40.3M | $96.7M | ||
| Q2 24 | $33.0M | $96.8M | ||
| Q1 24 | $45.4M | $107.2M |
总债务FSBWPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益FSBWPBYI
| Q4 25 | $307.7M | $130.3M | ||
| Q3 25 | $300.5M | $115.3M | ||
| Q2 25 | $297.2M | $104.7M | ||
| Q1 25 | $298.8M | $97.1M | ||
| Q4 24 | $295.8M | $92.1M | ||
| Q3 24 | $288.9M | $71.1M | ||
| Q2 24 | $284.0M | $48.5M | ||
| Q1 24 | $277.9M | $51.0M |
总资产FSBWPBYI
| Q4 25 | $3.2B | $216.3M | ||
| Q3 25 | $3.2B | $202.9M | ||
| Q2 25 | $3.2B | $194.9M | ||
| Q1 25 | $3.1B | $196.2M | ||
| Q4 24 | $3.0B | $213.3M | ||
| Q3 24 | $3.0B | $220.7M | ||
| Q2 24 | $2.9B | $205.0M | ||
| Q1 24 | $3.0B | $214.1M |
负债/权益比FSBWPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $51.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 129.8% | 19.1% |
| 资本支出强度资本支出/营收 | 50.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $107.2M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FSBWPBYI
| Q4 25 | $72.3M | $14.4M | ||
| Q3 25 | $44.6M | $9.7M | ||
| Q2 25 | $7.1M | $14.1M | ||
| Q1 25 | $8.2M | $3.6M | ||
| Q4 24 | $50.8M | $15.6M | ||
| Q3 24 | $-891.0K | $11.0M | ||
| Q2 24 | $9.9M | $1.0M | ||
| Q1 24 | $275.0K | $11.2M |
自由现金流FSBWPBYI
| Q4 25 | $51.9M | $14.4M | ||
| Q3 25 | $41.6M | $9.7M | ||
| Q2 25 | $5.9M | $14.1M | ||
| Q1 25 | $7.8M | $3.6M | ||
| Q4 24 | $49.2M | $15.6M | ||
| Q3 24 | $-1.5M | $11.0M | ||
| Q2 24 | $9.6M | $1.0M | ||
| Q1 24 | $-82.0K | — |
自由现金流率FSBWPBYI
| Q4 25 | 129.8% | 19.1% | ||
| Q3 25 | 105.9% | 17.7% | ||
| Q2 25 | 15.7% | 26.8% | ||
| Q1 25 | 21.7% | 7.7% | ||
| Q4 24 | 137.7% | 26.4% | ||
| Q3 24 | -4.1% | 13.7% | ||
| Q2 24 | 26.6% | 2.1% | ||
| Q1 24 | -0.2% | — |
资本支出强度FSBWPBYI
| Q4 25 | 50.9% | 0.0% | ||
| Q3 25 | 7.7% | 0.0% | ||
| Q2 25 | 3.5% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 4.6% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 0.8% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
现金转化率FSBWPBYI
| Q4 25 | — | — | ||
| Q3 25 | 4.86× | 1.10× | ||
| Q2 25 | 0.92× | 2.41× | ||
| Q1 25 | 1.02× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | 0.54× | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 0.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
